Clinical and analytical findings in Gitelman's syndrome associated with homozygosity for the c.1925 G>A SLC12A3 mutation

Am J Nephrol. 2009;30(3):218-21. doi: 10.1159/000218104. Epub 2009 May 7.

Abstract

Background: Gitelman's syndrome (GS) is caused by mutations in the SLC12A3. Most of the mutations are rare, making it difficult to establish a genotype-phenotype correlation. Although GS is a recessive disorder, some patients also have an affected parent, suggesting a dominant inheritance.

Methods: We sequenced the 26 coding exons of SLC12A3 in a family in which the proband and her father had a late onset GS. We obtained cDNA of the 2 patients and analyzed the effect of a mutation on pre-mRNA splicing.

Results: The 2 patients were homozygous for a nucleotide change in the last nucleotide of exon 15: c.1925 G>A. The mother was a heterozygous carrier for this putative mutation. Amplification of cDNA with primers for exons 14-17 was negative, suggesting that this mutation affected the splicing and promoted mRNA degradation through nonsense-mediated decay.

Conclusions: We report a family with 2 patients with late onset GS and homozygous for a mutation in the last nucleotide of exon 15. Our study shows that homozygosity for this mutation resulted in a significant loss of normal SLC12A3 transcript.

MeSH terms

  • Adult
  • Female
  • Gitelman Syndrome / genetics*
  • Homozygote
  • Humans
  • Male
  • Middle Aged
  • Mutation*
  • Receptors, Drug / genetics*
  • Solute Carrier Family 12, Member 3
  • Symporters / genetics*

Substances

  • Receptors, Drug
  • SLC12A3 protein, human
  • Solute Carrier Family 12, Member 3
  • Symporters